Microbiology

  1. Identification of unique mutations in SARS-CoV-2 strains isolated from India suggests its attenuated pathotype

    1. Shubham Gaurav
    2. Shambhavi Pandey
    3. Apurvasinh Puvar
    4. Tejas Shah
    5. Madhvi Joshi
    6. Chaitanya Joshi
    7. Sachin Kumar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type

    1. Paul R. Lephart
    2. Michael A. Bachman
    3. William LeBar
    4. Scott McClellan
    5. Karen Barron
    6. Lee Schroeder
    7. Duane W. Newton

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. An OpenData portal to share COVID-19 drug repurposing data in real time

    1. Kyle R. Brimacombe
    2. Tongan Zhao
    3. Richard T. Eastman
    4. Xin Hu
    5. Ke Wang
    6. Mark Backus
    7. Bolormaa Baljinnyam
    8. Catherine Z. Chen
    9. Lu Chen
    10. Tara Eicher
    11. Marc Ferrer
    12. Ying Fu
    13. Kirill Gorshkov
    14. Hui Guo
    15. Quinlin M. Hanson
    16. Zina Itkin
    17. Stephen C. Kales
    18. Carleen Klumpp-Thomas
    19. Emily M. Lee
    20. Sam Michael
    21. Tim Mierzwa
    22. Andrew Patt
    23. Manisha Pradhan
    24. Alex Renn
    25. Paul Shinn
    26. Jonathan H. Shrimp
    27. Amit Viraktamath
    28. Kelli M. Wilson
    29. Miao Xu
    30. Alexey V. Zakharov
    31. Wei Zhu
    32. Wei Zheng
    33. Anton Simeonov
    34. Ewy A. Mathé
    35. Donald C. Lo
    36. Matthew D. Hall
    37. Min Shen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen

    1. Dan Liu
    2. Chenhui Ju
    3. Chao Han
    4. Rui Shi
    5. Xuehui Chen
    6. Demin Duan
    7. Jinghua Yan
    8. Xiyun Yan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro

    1. Hua-Long Xiong
    2. Jia-Li Cao
    3. Chen-Guang Shen
    4. Jian Ma
    5. Xiao-Yang Qiao
    6. Tian-Shu Shi
    7. Sheng-Xiang Ge
    8. Hui-Ming Ye
    9. Jun Zhang
    10. Quan Yuan
    11. Tian-Ying Zhang
    12. Ning-Shao Xia

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans

    1. Rayhane Nchioua
    2. Dorota Kmiec
    3. Janis A. Müller
    4. Carina Conzelmann
    5. Rüdiger Groß
    6. Chad M. Swanson
    7. Stuart J. D. Neil
    8. Steffen Stenger
    9. Daniel Sauter
    10. Jan Münch
    11. Konstantin M. J. Sparrer
    12. Frank Kirchhoff

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Integrated genomic view of SARS-CoV-2 in India

    1. Pramod Kumar
    2. Rajesh Pandey
    3. Pooja Sharma
    4. Mahesh S. Dhar
    5. Vivekanand A.
    6. Bharathram Uppili
    7. Himanshu Vashisht
    8. Saruchi Wadhwa
    9. Nishu Tyagi
    10. Saman Fatihi
    11. Uma Sharma
    12. Priyanka Singh
    13. Hemlata Lall
    14. Meena Datta
    15. Poonam Gupta
    16. Nidhi Saini
    17. Aarti Tewari
    18. Bibhash Nandi
    19. Dhirendra Kumar
    20. Satyabrata Bag
    21. Deepanshi Gahlot
    22. Surabhi Rathore
    23. Nidhi Jatana
    24. Varun Jaiswal
    25. Hema Gogia
    26. Preeti Madan
    27. Simrita Singh
    28. Prateek Singh
    29. Debasis Dash
    30. Manju Bala
    31. Sandhya Kabra
    32. Sujeet Singh
    33. Mitali Mukerji
    34. Lipi Thukral
    35. Mohammed Faruq
    36. Anurag Agrawal
    37. Partha Rakshit

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Rapid detection of SARS-CoV-2 and other respiratory viruses by using LAMP method with Nanopore Flongle workflow

    1. Jingjing Li
    2. Weipeng Quan
    3. Shuge Yan
    4. Shuangju Wu
    5. Jianhu Qin
    6. Tingting Yang
    7. Fan Liang
    8. Depeng Wang
    9. Yu Liang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein

    1. Gunderao H. Kathwate

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain

    1. Simona Iftimie
    2. Ana F. López-Azcona
    3. Manuel Vicente-Miralles
    4. Ramon Descarrega-Reina
    5. Anna Hernández-Aguilera
    6. Francesc Riu
    7. Josep M. Simó
    8. Pedro Garrido
    9. Jorge Joven
    10. Jordi Camps
    11. Antoni Castro

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 54 of 246 Next